Short-term effect of vaginal erbium laser on the genitourinary syndrome of menopause

Minerva Ginecol. 2015 Apr;67(2):97-102.

Abstract

Aim: In this study we evaluated the short term effects of vaginal erbium laser (VEL) in the treatment of postmenopausal women (PMW) suffering from genitourinary syndrome of menopause (GSM).

Methods: Sixty-five PMW were evaluated before and after VEL treatment (1 treatment every 30 days, for 3 months). GSM symptoms were evaluated either with subjective (Visual Analog Scale, VAS) and objective (Vaginal Health Index Score, VHIS) measures. In addition, in 21 of these PMW suffering from mild-moderate stress urinary incontinence (SUI), the degree of incontinence was evaluated with the International Consultation on Incontinence Questionnaire - Urinary Incontinence Short Form (ICIQ-UI SF) before and after VEL treatments.

Results: VEL treatment induced a significant decrease of VAS of both vaginal dryness, dyspareunia (P<0.01) and a significant (P<0.01) increase of VHIS). In addition, VEL treatment induced a significant (P<0.01) improvement of ICIQ-SF scores in PMW suffering from SUI. VEL was well tolerated with less than 2 % of patients discontinuing treatment due to adverse events.

Conclusion: VEL treatment significantly improves vaginal dryness, dyspareunia and mild-moderate SUI. Larger and long-term studies are needed to investigate the role of laser treatments in the management of GSM.

MeSH terms

  • Aged
  • Dyspareunia / etiology
  • Dyspareunia / therapy
  • Female
  • Genital Diseases, Female / etiology
  • Genital Diseases, Female / therapy*
  • Humans
  • Lasers, Solid-State / adverse effects
  • Lasers, Solid-State / therapeutic use*
  • Menopause*
  • Middle Aged
  • Prospective Studies
  • Surveys and Questionnaires
  • Treatment Outcome
  • Urinary Incontinence, Stress / therapy
  • Vagina
  • Vaginal Diseases / etiology
  • Vaginal Diseases / therapy*